跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
OR-105
首页
药物
OR-105
OR-105
未知生产厂商
订阅
生成 AI 研报
Share to Twitter
Share to Facebook
Share to LinkedIn
Share to Reddit
摘要
临床试验
审批记录
专利
每项发明一条,涵盖美国、欧洲、PCT 与中国的同族专利。
Planar explosive LLM-105 solvate as well as preparation method and application thereof
申请人: INST CHEMICAL MATERIAL CHINA ACADEMY ENGINEERING PHYSICS
优先权: 2021
CN
Composition for treating livestock diseases
申请人: CHEN HENGGAO
优先权: 2017
CN
High-affinity TCR for NY-ESO
申请人: XLIFESC LTD
优先权: 2016
US
Medicine composition for treating and/or auxiliarily treating ischemic cardiomyopathy and preparation method and application thereof
申请人: SOUTHWEST MEDICAL UNIV AFFILIATED HOSPITAL OF TRADITIONAL CHINESE MEDICINE
优先权: 2017
CN
Medicine for treating gout, gastropathy and constipation and preparation method of medicine
申请人: HENGCITANG HEALTH MAN HENAN CO LTD
优先权: 2020
CN
METHOD FOR INHIBITING CRYSTALLISATION
申请人: BIOSYNTHIS SARL
优先权: 2021
CN
US
2 件公开
Antibody formulations and uses thereof
申请人: TRACON PHARMACEUTICALS INC
优先权: 2012
CN
2 件公开
Medicine composition for treating or adjunctively treating pulmonary heart disease, and preparation method and application thereof
申请人: THE AFFILIATED HOSPITAL OF TRADITIONAL CHINESE MEDICAL TO SOUTHWEST MEDICAL UNIV
优先权: 2017
CN
药物
反馈